NEOG - Neogen Corporation
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Treasury yields and oil prices weigh on stock futures this morning, with all three major indexes lower ahead of the open
Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031. The event featured presentations from Mike Nassif, President and Chief Executive Officer; Bryan Riggsbee, Chief.
Neogen Corporation ( NEOG ) Analyst/Investor Day October 7, 2026 9:00 AM EDT Company Participants Bill Waelke Mikhael Nassif - CEO, President & Director Tamara Ranalli - Senior VP & GM of Global Food Safety Joe Freels - Senior VP & Chief Commercial Officer Jeremy Yarwood - Chief Scientific Officer Jim Walter R. Riggsbee - CFO & Senior Vice President Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C.
Neogen (NEOG) shares are down following a strong Q1 (August) earnings report. The decline seems to stem from the fact that while headline growth was impressive,
Neogen Corp. (NASDAQ:NEOG) stock fell on Wednesday even after the company reported better-than-expected first-quarter financial results.
Neogen (NEOG) Securities Investigation Notice - Levi and KorsinskyPR NewswireNEW YORK, Oct. 7, 2026 Neogen shares fell 7.22% after an FDA warning concerning the r
Neogen shares fell 7.22% after an FDA warning concerning the recalled Neogen Vet product HYCOAT, which reporting tied to fungal contamination and at least 20 horse deaths. NEW YORK, Oct. 7, 2026 /PRNewswire/ -- Neogen (NASDAQ: NEOG) shares fell over 7% after an FDA warning concerning HYCOAT, a recalled Neogen Vet product that reporting linked to fungal contamination and at least 20 horse deaths.
Stock futures are lower as oil prices and Treasury yields rise, while investors await minutes from the Federal Reserve's September meeting
Neogen (NASDAQ: NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition. Chief Executive Officer Mike Nassif said the quarter marked an acceleration from the prior quarter, though he noted
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation (NEOG) Q1 2027 Earnings Call Transcript
Neogen NASDAQ: NEOG reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition.
Neogen (NEOG) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.04 per share a year ago.
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027. “As we entered fiscal year 2027, our focus shifted from strengthening fundamentals to scaling them to drive more consistent execution, improved customer outcomes and profitable growth,” said Mike Nassif, Neogen's President and Chief Executive Officer. “Our first-quarter results reflect encouraging progress.
Neogen Corporation (NASDAQ: NEOG), a global leader in food safety solutions, is advancing its innovation strategy by combining deep food safety expertise with